Alexandria Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Alexandria Capital's ELV Position: Q3 2021 in Review
Alexandria Capital increased its Elevance Health (ELV) stake by 0.03% in Q3 2021, buying an estimated $1.9K and bringing the position to 16,232 shares worth $6.05M. The position accounts for 0.56% of the portfolio, ranked #67.
Alexandria Capital first reported a position in ELV in Q4 2017 and has held it in 16 quarters since. The position peaked at $6.2M in Q2 2021. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.
- Alexandria Capital held 16,232 shares of Elevance Health worth $6.05M as of Q3 2021.
- Alexandria Capital bought 5 Elevance Health shares in Q3 2021, an estimated $1.9K.
- Elevance Health made up 0.56% of Alexandria Capital's portfolio in Q3 2021, its #67 holding.
- Alexandria Capital first reported a position in Elevance Health in Q4 2017 and has held it in 16 quarters since.
- Alexandria Capital's Elevance Health position peaked at $6.2M in Q2 2021.
- 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.
Based on Alexandria Capital's 13F filing for Q3 2021, filed 2 Dec 2021.